Hazlet, NJ, United States of America

Thomas A Re

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas A Re: Innovator in Transdermal Technology

Introduction

Thomas A Re is a notable inventor based in Hazlet, NJ (US). He has made significant contributions to the field of pharmacology, particularly in enhancing transdermal penetration of active agents. With a total of 2 patents to his name, his work has implications for both medical and cosmetic applications.

Latest Patents

Thomas A Re's latest patents include a method for enhancing transdermal penetration and compositions useful for this purpose. The first patent provides a composition containing a pharmacologically active agent and a selected imidazole or an imidazole derivative. This composition exhibits enhanced penetration of the active agent when applied to the skin. The second patent focuses on an antiperspirant process utilizing imidazole-containing compositions. This process effectively decreases perspiration in targeted areas of the skin by applying an antiperspirant amount of an imidazole derivative.

Career Highlights

Thomas A Re is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at this esteemed organization has allowed him to further his research and development in innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Michael D Helman and Alison B Lukacsko. Their collaborative efforts contribute to the advancement of research in their respective fields.

Conclusion

Thomas A Re's innovative work in transdermal technology showcases his commitment to enhancing the effectiveness of pharmacological treatments. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…